General Information of Drug (ID: DM8ZROW)

Drug Name
SNDX-6352 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM8ZROW

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pexidartinib DMS2J0Z Tenosynovial giant cell tumour 2F7B Approved [2]
Sulfatinib DMPOTM4 Neuroendocrine cancer 2B72.1 Phase 3 [1]
ARRY-382 DM0VGDC Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
BLZ-945 DMG1LVA Amyotrophic lateral sclerosis 8B60.0 Phase 2 [1]
Cabiralizumab DMGE058 Pancreatic cancer 2C10 Phase 2 [3]
AMB-05X DM958C5 Idiopathic pulmonary fibrosis CB03.4 Phase 2 [4]
FPA-008 DM3ZN6Y Autoimmune diabetes 5A10 Phase 1/2 [5]
DCC-3014 DMHW289 Solid tumour/cancer 2A00-2F9Z Phase 1/2 [1]
DCC-3014 DMHW289 Solid tumour/cancer 2A00-2F9Z Phase 1/2 [6]
PLX7486 DM0IVGU Pancreatic cancer 2C10 Phase 1 [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Macrophage colony-stimulating factor 1 receptor (CSF1R) TT7MRDV CSF1R_HUMAN Antagonist [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Clinical pipeline report, company report or official report of AmMax Bio
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6 Clinical pipeline report, company report or official report of Deciphera Pharmaceuticals.